Company / EPS (Diluted)
MIMEDX GROUP, INC. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.32
FY2025
5-year range
-$0.33 / $0.37
FY2021-FY2025
Trend
+14.3%
vs FY2024
Sector context
#91 of 155
Health Care
What the data says
At $0.32, MIMEDX GROUP, INC.'s eps (diluted) ranks #91 of 155 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $-0.77 in FY2020 to $0.56 in FY2017.
Based on SEC 10-K filings.
0.32 in FY2025.
Declined from $0.37 to $0.32 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#91 of 155 in Health CareTop 59% of 155This company $0.32 Sector average $2.33
▼
-86.3% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 14.3% year-over-year.
- Ranks #91 out of 155 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2017.
- Lowest eps (diluted) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 3.50 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.32 | +14.3% |
| FY2024 | $0.28 | -24.3% |
| FY2023 | $0.37 | +212.1% |
| FY2022 | -$0.33 | -120.0% |
| FY2021 | -$0.15 | +80.5% |
| FY2020 | -$0.77 | -220.8% |
| FY2019 | -$0.24 | +14.3% |
| FY2018 | -$0.28 | -150.0% |
| FY2017 | $0.56 | - |
| FY2016 | $0.00 | -100.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026